What is the appropriate evaluation and management for a 28‑week pregnant woman with serum albumin 2.1 g/dL and thalassemia trait?

Evaluation and Management of Low Albumin in a 28-Week Pregnant Woman with Thalassemia Trait

This patient requires immediate evaluation for preeclampsia and close monitoring, as the combination of low albumin (2.1 g/dL) at 28 weeks with thalassemia trait significantly increases her risk for hypertensive disorders and adverse pregnancy outcomes.

Immediate Assessment Required

The serum albumin of 2.1 g/dL is markedly low and demands urgent evaluation. While physiologic hemodilution causes albumin to decrease in pregnancy (normal third trimester values are approximately 33-37 g/L or 3.3-3.7 g/dL) 1, this patient's level falls well below the physiologic range and raises serious concerns.

Priority Evaluation for Preeclampsia

Check immediately:

• Blood pressure (looking for ≥140/90 mmHg after 20 weeks) 2
• Urine protein-to-creatinine ratio (abnormal if ≥30 mg/mmol or 0.3 mg/mg) 2
• Complete blood count with platelet count 2
• Liver enzymes (AST, ALT, LDH) and liver function tests (INR, bilirubin, albumin) 2
• Serum creatinine, electrolytes, and uric acid 2

Critical thresholds to recognize:

• Albumin ≤3.0 g/dL correlates with severe proteinuria (>2 g/day) 3
• Albumin <2.5 g/dL significantly increases risk of ascites (OR 3.5), HELLP syndrome (OR 12), and perinatal mortality (OR 6.1) 3

This patient's albumin of 2.1 g/dL places her in the highest risk category.

Thalassemia Trait Considerations

The thalassemia trait adds complexity to this clinical picture. Determine the specific type of thalassemia trait (α-thalassemia-1, β-thalassemia, or HbE trait) through hemoglobin typing if not already documented 4, 5.

Expected Hematologic Findings

Women with thalassemia traits typically have:

• Lower hematocrit in first trimester (mean 34.8% vs 36.9% in controls) 4
• Increased maternal anemia throughout pregnancy 4
• β-thalassemia and HbE traits specifically increase risk of pregnancy-induced hypertension (RR 1.67 and 1.66 respectively) 4

The combination of thalassemia trait and low albumin creates compounded risk for preeclampsia 4, 6.

Diagnostic Algorithm

If Hypertension Present (BP ≥140/90 mmHg):

Diagnose preeclampsia if hypertension PLUS any of the following:

• Proteinuria (PCR ≥30 mg/mmol)
• Thrombocytopenia
• Elevated liver enzymes
• Renal insufficiency (creatinine >1.1 mg/dL)
• Pulmonary edema
• New-onset headache or visual symptoms 2

Note: Proteinuria is present in only ~75% of preeclampsia cases; its absence does not exclude the diagnosis 2.

If No Hypertension Currently:

This patient still requires intensive surveillance given:

1. Severely low albumin (2.1 g/dL) predicting imminent complications 3
2. Thalassemia trait increasing preeclampsia risk 4, 6
3. 28 weeks gestation (peak risk period for gestational hypertension/preeclampsia)

Management Strategy

For Confirmed or Suspected Preeclampsia:

Antihypertensive therapy if BP ≥140/90 mmHg:

• First-line: Oral labetalol, nifedipine, or methyldopa 7
• For severe hypertension (≥160/110 mmHg): Urgent treatment with IV labetalol or hydralazine 7

Magnesium sulfate for seizure prophylaxis if severe hypertension present 7

Aspirin 150 mg nightly should have been started before 16 weeks if risk factors identified, but is too late to initiate at 28 weeks 2

Anemia Management with Thalassemia Trait:

Do NOT treat with iron supplementation if thalassemia trait is confirmed 8. The CDC guidelines explicitly state that mild anemia unresponsive to iron therapy in women of Mediterranean, African, or Southeast Asian ancestry may be due to thalassemia trait 8.

If anemia is present beyond what's expected for thalassemia trait:

• Verify hemoglobin typing to confirm trait vs. disease
• Check ferritin if iron deficiency is suspected as a co-existing condition
• Maintain hemoglobin >9 g/dL through monitoring 9

Monitoring Intensity:

Weekly or twice-weekly visits with:

• Blood pressure checks
• Symptom assessment (headache, visual changes, right upper quadrant pain)
• Laboratory monitoring (CBC, liver enzymes, creatinine, albumin)
• Fetal surveillance (NST, growth ultrasounds every 2-3 weeks)

Delivery Planning

Albumin level correlates with time to delivery (positive correlation, r=0.389) 3. With albumin at 2.1 g/dL, anticipate potential need for delivery in the near term if preeclampsia develops or worsens.

Delivery indications include:

• Severe hypertension uncontrolled on multiple agents 2
• Progressive thrombocytopenia 2
• Worsening liver or renal function 2
• Pulmonary edema 2
• Eclamptic seizures 2
• Non-reassuring fetal status 2

Critical Pitfalls to Avoid

1. Do not dismiss low albumin as "normal for pregnancy" – 2.1 g/dL is pathologic and predicts severe complications 3
2. Do not give iron supplementation without confirming iron deficiency – thalassemia trait patients do not benefit and may experience iron overload 8
3. Do not wait for proteinuria to diagnose preeclampsia – 25% of cases lack proteinuria 2
4. Do not use NSAIDs for analgesia if preeclampsia develops, especially with low albumin suggesting potential renal involvement 2